Mortality before hospital discharge · feed interruption while monitoring gastric residual
Summary of findings table ‐ Quality and volume of gastric residual showed no clear difference in all‐cause mortality before hospital discharge compared with quality of gastric residual alone (low certainty).
1 finding from 1 review
All‐cause mortality · individuals with sickle cell disease who are at risk of a primary stroke who have had long‐term red cell transfusions to prevent a stroke
1 finding from 1 review
All‐cause mortality · individuals with sickle cell disease who are at risk of a primary stroke who have not had previous long‐term red cell transfusions
1 finding from 1 review
All‐cause mortality · individuals with sickle cell disease who have had a stroke who have had long‐term red cell transfusions to prevent another stroke
It is very uncertain whether long‐term red cell transfusion changes all‐cause mortality compared with hydroxyurea and phlebotomy (very low certainty).
1 finding from 1 review
All‐cause mortality · individuals with sickle cell disease who are at risk of a primary stroke who have had long‐term red cell transfusions to prevent a stroke
It is very uncertain whether long‐term red cell transfusion changes all‐cause mortality compared with no transfusion (very low certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality · individuals with atrial fibrillation who are undergoing cardiac surgery
The intervention showed no clear difference in all‐cause mortality (low certainty).
1 finding from 1 review
All‐cause mortality · healthy participants or recruited among the general population; individuals diagnosed with a specific disease in a stable phase or with…
Vitamin D may leads to lower all‐cause mortality compared with placebo or no intervention (low certainty).
1 finding from 1 review
Intervention not reported
All‐cause Mortality ‐ Flexible sigmoidoscopy · Asymptomatic individuals
The intervention showed no clear difference in all‐cause Mortality ‐ Flexible sigmoidoscopy (high certainty).
1 finding from 1 review
Mortality before hospital discharge · preterm infants
Summary of findings table ‐ routine monitoring showed no clear difference in all‐cause mortality before hospital discharge compared with no routine monitoring of gastric residual (low certainty).
1 finding from 1 review
Mortality before hospital discharge · preterm infants
Summary of findings table ‐ Re‐feeding showed no clear difference in all‐cause mortality before hospital discharge compared with discarding gastric residuals (low certainty).
1 finding from 1 review
Mortality (all‐cause) · acute exacerbations of chronic obstructive pulmonary disease
Action plan showed no clear difference in mortality (all‐cause) compared with usual care (moderate certainty).
1 finding from 1 review
Intervention not reported
All‐cause Mortality ‐ Faecal occult blood testing · Asymptomatic individuals
The intervention leads to higher all‐cause Mortality ‐ Faecal occult blood testing (high certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality Median · individuals without known diabetes mellitus but at high risk for the condition
The intervention showed no clear difference in all‐cause mortality Median (low certainty).
1 finding from 1 review
All‐cause mortality at day 28 · individuals with moderate or severe COVID‐19
Hyperimmune immunoglobulin from human plasma showed no clear difference in all‐cause mortality at day 28 compared with saline placebo (low certainty).
1 finding from 1 review
RR 0.79 [0.43, 1.44]
Studies not reported
Low
All‐cause mortality (by day 28) · individuals with moderate or severe COVID‐19
RBD‐specific polyclonal F(ab') 2 fragments of equine antibodies… showed no clear difference in all‐cause mortality (by day 28) compared with saline placebo (low certainty).
1 finding from 1 review
All‐cause mortality up to 30 days · hospitalised and unvaccinated individuals with a confirmed or suspected diagnosis of symptomatic COVID‐19
Summary of findings table ‐ Corticosteroids plus standard care probably leads to lower all‐cause mortality up to 30 days compared with standard care (plus/minus placebo) (moderate certainty).
1 finding from 1 review
All‐cause mortality up to 30 days · hospitalised individuals with unknown vaccination status and a confirmed diagnosis of symptomatic COVID‐19
Summary of findings table ‐ High‐dose dexamethasone (12 mg or higher) showed no clear difference in all‐cause mortality up to 30 days compared with low‐dose dexamethasone (6 mg to 8 mg) (low certainty).
1 finding from 1 review
All‐cause mortality up to 30 days · hospitalised and unvaccinated individuals with a confirmed or suspected diagnosis of symptomatic COVID‐19
It is very uncertain whether summary of findings table ‐ Methylprednisolone changes all‐cause mortality up to 30 days compared with dexamethasone (very low certainty).
1 finding from 1 review
All‐cause mortality up to 120 days · hospitalised individuals with unknown vaccination status and a confirmed diagnosis of symptomatic COVID‐19
It is very uncertain whether summary of findings table ‐ High‐dose dexamethasone (12 mg or higher) changes all‐cause mortality up to 120 days compared with low‐dose dexamethasone (6 mg to 8 mg) (very low certainty).
1 finding from 1 review
All‐cause mortality up to 120 days · hospitalised and unvaccinated individuals with a confirmed or suspected diagnosis of symptomatic COVID‐19
It is very uncertain whether summary of findings table ‐ Corticosteroids plus standard care changes all‐cause mortality up to 120 days compared with standard care (plus/minus placebo) (very low certainty).
1 finding from 1 review